Financial Counselors Inc. boosted its stake in shares of China Cord Blood Corporation (NYSE:CO) by 6.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 92,056 shares of the medical research company’s stock after buying an additional 5,226 shares during the period. Financial Counselors Inc. owned about 0.13% of China Cord Blood Corporation worth $613,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently added to or reduced their stakes in the stock. Spark Investment Management LLC bought a new stake in China Cord Blood Corporation during the first quarter worth $204,000. Brandes Investment Partners LP purchased a new position in shares of China Cord Blood Corporation during the first quarter worth approximately $263,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in China Cord Blood Corporation by 12.2% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 40,870 shares of the medical research company’s stock valued at $272,000 after buying an additional 4,442 shares in the last quarter. Acadian Asset Management LLC increased its position in China Cord Blood Corporation by 3.3% in the first quarter. Acadian Asset Management LLC now owns 590,403 shares of the medical research company’s stock valued at $3,932,000 after buying an additional 18,801 shares in the last quarter. Finally, GLG Partners LP increased its position in China Cord Blood Corporation by 56.0% in the fourth quarter. GLG Partners LP now owns 1,608,388 shares of the medical research company’s stock valued at $9,843,000 after buying an additional 577,518 shares in the last quarter. 18.23% of the stock is currently owned by hedge funds and other institutional investors.
Shares of China Cord Blood Corporation (NYSE:CO) traded down 2.16% during midday trading on Tuesday, hitting $8.62. 68,266 shares of the stock traded hands. The firm has a 50-day moving average price of $8.05 and a 200 day moving average price of $6.51. The stock has a market cap of $629.29 million, a price-to-earnings ratio of 44.43 and a beta of 0.85. China Cord Blood Corporation has a one year low of $4.27 and a one year high of $9.25.
ILLEGAL ACTIVITY WARNING: “Financial Counselors Inc. Acquires 5,226 Shares of China Cord Blood Corporation (CO)” was published by Stock Observer and is the property of of Stock Observer. If you are reading this news story on another publication, it was illegally copied and republished in violation of United States & international copyright law. The legal version of this news story can be viewed at https://www.thestockobserver.com/2017/06/20/china-cord-blood-corp-co-shares-bought-by-financial-counselors-inc-updated-updated.html.
China Cord Blood Corporation Company Profile
China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee.
Receive News & Ratings for China Cord Blood Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Cord Blood Corporation and related companies with MarketBeat.com's FREE daily email newsletter.